A191420 Share Price Performance
₩0
-19180.00 (-100.00%)
Price ₩0
Share Pricen/a
Analysis Article • Jan 28
TegoScience Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
A191420 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
TegoScience Inc. Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
- -1.04k
- 66.45%
- -143.46%
- 33.8%
About A191420
- Founded
- 2001
- Employees
- 42
- CEO
- WebsiteView website
TegoScience Inc., a biotechnology-based cosmetics company, engages in the production of various skin cell therapy products originating from human epithelial cells in South Korea. The company offers Holoderm, a commercialized cultured skin autograft; Kaloderm, an allogeneic cell therapy product for healing wounds; Rosmir, a fibroblast cell therapy; and Neoderm, a three-dimensionally cultured skin model. It also provides KCM for skin regeneration effect; Chemotide, a single-chain human peptide; contract research services, such as biologics quality control services and histology services; and SkinBank, an insurance for cells, as well as engages in cell therapy business. The company was founded in 2001 and is headquartered in Seoul, South Korea.
